This study examined the development of respiration during the preterm and early post-term periods and the effects of other biological and environmental variables, including sleep state, on this development.
INTRODUCTION
Respiration of preterm infants is affected by both maturation and sleep state. For example, preterm infants have more apnea and higher respiration rates than full-terms, even after term. [1] [2] [3] [4] [5] [6] [7] Brief respiratory pauses (less than 20 seconds) occur more often in active sleep than quiet sleep for both full-term and preterm infants but are longer in quiet sleep. 1, 4, [7] [8] [9] [10] [11] [12] [13] Respiration rates are higher and more variable in active sleep. 14, 15 Some studies found that periodic respiration (a cyclic pattern of breathing and apnea) occurs more often in active sleep; 8, 16, 17 others found no differences. 11, 12, 18 Neural control of breathing is also different in different states. 19 Arterial oxygen and carbon dioxide levels are lower in active than quiet sleep possibly due to hypoventilation or ventilation-perfusion inequalities in active sleep. 20, 21 Responses to hypoxia and hypercapnia are reduced during active sleep. 22, 23 Apnea severity is associated with neurological insults. 24, 25 Thus, respiratory development reflects changes in both lung mechanics and central nervous system (CNS) maturation.
Despite the relationship between respiratory development and brain maturation, only limited research has examined the maturation of respiratory patterns, except for the clinically important problem of pathological apnea, in preterm infants from the preterm period through the early weeks after term. Only three studies of the development of brief respiratory pauses, all conducted more than 15 years ago, have been longitudinal and spanned the preterm and early post-term periods. 4, 5, 11 The development of respiration rates has not yet been examined longitudinally.
When studied either before or after term, both pathologic apnea and brief respiratory pauses decreased in frequency and length with age. 4, 12, 12, 26, 27 Findings about periodic breathing were less clear, with some studies finding no change over age 12 and others finding a decrease. 3, 5, 7 Also, little is known about environmental and biological factors affecting these developmental changes.
The purpose of this study was to examine the development of respiratory behaviors during the preterm and early post-term periods, the effects of specific biological and environmental variables on developmental patterns, and the extent to which these variables differed between active and quiet sleep. In particular, we examined how developmental patterns were affected by infant characteristics (gender, race), illness severity and treatments (birthweight, length of mechanical ventilation, methylxanthine (theophylline or caffeine) treatment), and hospital site.
MATERIALS AND METHODS Participants
The sample was 134 preterm infants who either weighed less than 1500 g at birth or required mechanical ventilation or continuous positive airway pressure; 90 had both problems. Infants with congenital neurological problems (e.g., microcephaly or Trisomy 21) were excluded. All other infants were eligible. Infants were recruited from three hospitals: 75 from a southeastern tertiary perinatal center, five from a northeastern tertiary perinatal center, and 54 from a midwestern children's hospital. These infants were subjects in a larger study of the developmental outcomes of preterm infants, and sample size had been determined to have a statistical power of better than 0.80 for detecting a difference between subjects of 5 points in mental development. This sample size should also be adequate for determining the early development of respiratory patterns.
The infants averaged 28.8 weeks gestational age and a birthweight of 1218 g. They were 54% male and were 47% African American, 52% white, and 1% Asian. They averaged 11.5 days of mechanical ventilation and 1.2 infections. They averaged 2.8 on the Neurobiologic Risk Scale (NBRS); 28 17% had a Grade I or II intraventricular hemorrhage (IVH), and 5% had a Grade III or IV IVH. The two smallest sub-samples (northeastern and midwestern hospitals) were combined and compared with the other hospital using w 2 -tests for categorical variables and t-tests for continuous variables. The southeastern hospital infants had significantly higher NBRS scores (3.4 vs 2.1); were more likely to be multiple births (34.7 vs 16.9%) and first-born (68.0 vs 42.4%); had more infections (1.5 vs 0.7); and were more likely to be treated with indomethicin (58.7 vs 16.9%), fentanyl (54.7 vs 3.4%), cisapride (33.3 vs 3.4%), and ranitidine (36.0 vs 11.9%).
Variables Used for Data Analyses
Sleep states. Active and quiet sleep were judged based on eye opening, movements, muscle tone, eye movements, and respiration using previously published definitions. 12 Apnea. Computer-assisted scoring was used for apnea. An apneic episode was defined by the absence of respiratory activity for more than 2 seconds between the end of expiration and the beginning of inspiration. 12 Thus, only central apnea and the central components of mixed apnea were measured. Most apneas in preterm infants are central or mixed, 4 ,29 so few apneic events would have been missed. The apnea length was determined by measuring from the end of expiration to the beginning of inspiration. Apnea was considered to be pathologic if it lasted at least 20 seconds or occurred with hypoxemia, 30 indicated by heart rate of 95 or below on the infant's cardiac monitor or, if the infant was attached to a pulse oximeter, by a decrease of 10% in oxygen saturation. Apneas of less than 20 seconds and without hypoxemia were called respiratory pauses.
The variables used in analyses were the mean length in seconds of respiratory pauses in each sleep state, the standard deviation of the length of respiratory pauses in each sleep state, and frequency of respiratory pauses per hour of each sleep state. Dichotomous pathologic apnea variables were used F the presence or absence of pathologic apnea in each sleep state F since only a few subjects had pathologic apnea in any week and they usually had only one or two episodes.
Periodic respiration. Periodic respiration was scored on the respiration tape whenever there was a rhythmic pattern of apnea alternating with periods of breathing, using previously published definitions. 12 Since most infants did not display periodic respiration, periodic respiration was measured a dichotomous variable: the presence or absence in each sleep state.
Respiration rates. Respiration rates were obtained from the respiration recording by counting the number of breaths in a representative 30-second sample of each successive 2-minute sleep period. To avoid confounding respiration rate with other measures of respiration and activity, samples were selected so as not to include apnea, movements, hiccups, or sighs. The measures used were the mean and standard deviation of respiration rates in active sleep and in quiet sleep.
Infant characteristics. Information on 15 characteristics of the infants was obtained from the medical record: postconceptional age; birthweight; race; gender; number of infections; days of mechanical ventilation; treatment with methylxanthines, indomethicin, cisapride, metoclopramide, ranitidine, and fentanyl; severity of neurological insults; multiple birth; and hospital site. Cisapride, metoclopramide, and ranitidine treatment variables controlled for the effects of gastroesophageal reflux as well as medication effects. Hospital site was covaried to control for systematic differences between the sites. Postconceptional age and methylxanthine (theophylline or caffeine) treatment were scored at each observation; other variables were scored over hospitalization. Postconceptional age was the number of weeks since birth added to gestational age at birth, which was calculated from the obstetric estimated date of confinement, determined either by the date of the mother's last menstrual period or by an ultrasound examination and confirmed by a gestational age assessment 31 conducted by a pediatrician after birth. Whether or not the infant received a therapeutic dose of a methylxanthine at each observation and the total days of methylxanthines were determined.
To determine the severity of neurological insults, medical record data were scored on the Neurobiologic Risk Scale, 28 which measures potential CNS insults of direct injury or inadequate blood flow or nutrients. Seven neurological insults are scored on a 4-point scale, with higher scores indicating more severe insults. Scores on the NBRS are correlated with the Bayley MDI and PDI obtained at 6 to 24 months corrected age and with neurological examinations at 6 and 15 months. 28 Race was scored as either white or minority. Birthweight was coded so its mean value was zero and other values were the number of grams greater or less than the mean. Since the days of mechanical ventilation was highly skewed (mean 11.5, SD 18.7), infants with 1 day or less of mechanical ventilation were scored as receiving 1 day, and the natural logarithm of each subject's score was used in analyses. For the hospital site variable, the southeastern hospital was scored as one, and the other two hospitals were combined and scored as zero.
Procedures Each hospital's institutional committee for protection of human subjects approved the study. Infants were enrolled when their medical conditions were no longer critical (not receiving mechanical ventilation or in an immediate life-threatening situation) if an additional hospital stay of at least 1 week was anticipated and informed consent was obtained from the mothers. Weekly observations ended when infants had eight observations, reached 44 weeks postconceptional age, or were discharged from the hospital. Thus, the ages at which subjects were studied varied.
Infant sleep was observed once a week during a 2-hour interfeeding period to minimize handling. A mean of 3.3 observations per infant was obtained during hospitalization. At a signal from a small electronic timer, the observer recorded the predominant sleep-wake state for each 10-second period in the observation. 12 Each observation was conducted by one of nine observers; inter-rater reliability (Cohen's kappa) was 0.93 for active sleep and 0.86 for quiet sleep. A total of 90 infants returned to the hospital for a naptime observation using the same procedures 1 to 3 months later. The mean age at this follow-up observation was 49.3 weeks postconceptional age (SD 4.2).
The infant's respiration was recorded onto a computer file from a piezoelectric sensor pad placed under the infant's crib pad. The infant continued on regular heart and apnea monitors. The first author then scored the computer file for apnea and respiration rates using computer-assisted scoring. Intrarater reliability for apneas was determined by comparing hand scoring with computerassisted scoring: the kappa was 0.86. In addition, respiration files were re-scored by computer-assisted scoring several months after they were originally scored; the kappa was 0.89.
Data Analysis
The general linear mixed model, or mixed model, was the primary statistical method. [32] [33] [34] It is a flexible statistical procedure for analyzing continuous longitudinal data and appropriately accommodates missing values and mistimed data. As an extension to a repeated measures regression model, it assesses the relationship between continuous outcome measures and covariates. Parameterization of the mixed model includes population (fixed) effects while simultaneously fitting individual (random) effects. Since the respiratory variables were skewed, these variables were transformed to their natural logarithms for mixed model analysis. Since pathologic apnea and periodic respiration were categorized as present or not present in each observation, generalized estimating equations (GEE) 35 were used to analyze these variables. The GEE approach provides a population-averaged estimate of the probability of these variables in each sleep state at each age.
Respiratory variables were regressed over the linear and quadratic effects of postconceptional age. Hospital, gender, race, birthweight, length of mechanical ventilation, and methylxanthine treatment and the interactions of these variables with age were used as covariates. Individuals' deviations from the intercept and from the linear effect of postconceptional age were included in the random effects component of the mixed model. Subtracting 29 from the postconceptional ages made the intercept more easily interpretable, as it then corresponded to week 29.
A backward elimination process was used to develop the final model. The simultaneous effect of the interactions between postconceptional age and the covariates was tested first. 34 Then, the joint main effect of the covariates was tested first as a single hypothesis. 34 Then, the main effects of each covariate were tested simultaneously. The quadratic effect of postconceptional age was tested next, and finally postconceptional age was tested. Variables remaining after this screening with p<0.05 comprised a final mixed model. Valid covariance matrices were not obtained in the final models for the mean length and standard deviation of respiratory pauses in quiet sleep, so only random intercepts (but not random slopes) were included for these variables.
To determine whether each respiratory variable differed between active and quiet sleep, the difference in the percent of each behavior in active and quiet sleep was determined for each subject at each age. A mixed model determined the developmental pattern of the difference scores. A significant intercept indicated the percent of the behavior differed between the sleep states at 29 weeks. A significant postconceptional age effect indicated that the size of difference between the states changed over age. Periodic respiration was analyzed only in the 93 infants who showed this variable on at least one study session. Pathologic apnea was not analyzed due to its low incidence.
RESULTS
A total of 527 observations were conducted, 437 from 28 to 43 weeks postconceptional age and 90 from follow-up observations. One to nine observations were obtained on each infant. Only 22 observations, all between 30 and 36 weeks, had pathologic apnea in active sleep; 16 observations between 29 to 37 weeks and 1 at 43 weeks had pathologic apnea in quiet sleep. Observations were omitted from analyses because a respiratory recording was not obtained in one state (one in active sleep, three in quiet sleep) or both states (two observations). In all, 11 observations lacked quiet sleep so were not used in analyses of quiet sleep variables. Others were omitted from analyses of respiratory pauses because respiratory pauses did not occur (14 in active sleep, 88 in quiet sleep), of respiration rates because rates were not scored due to technical problems (four in active sleep, three in quiet sleep), or of standard deviations because the variable occurred only once in the state (respiratory pauses F eight in active sleep, 64 in quiet sleep; respiration rate F one in active sleep, five in quiet sleep).
Changes over Age
As Table 1 indicates, all respiratory variables, except three, had significant linear changes over age (see Figures 1,2,3,4) . The mean length of respiratory pauses in quiet sleep did not show significant development. The probability of pathologic apnea in active sleep and the variability of respiration rates in quiet sleep showed curvilinear decreases that slowed after 44 weeks, as indicated by a significant quadratic effect (see Figures 3 and 4) . The mean length and the variability of respiratory pauses in active sleep showed a significant quadratic effect as well as a linear decrease. As the result, the rate of the decrease slowed after 44 weeks postconceptional age (see Figure 1) . Table 1 also shows the variances of the random intercepts and slopes for postconceptional age effect for the individual infants and the correlations between them. The individual slopes and intercepts were negatively correlated, except the variability of respiratory pauses in active sleep, indicating that as an individual's intercept deviation increased, his slope deviation decreased. The individual patterns were similar to those of the group though respiratory pause frequencies showed skewed distributions with some subjects having high initial values and more rapid decreases. Note: Effects in the mixed models are for the natural logarithms of the actual values. Resp. ¼ respiratory, AS ¼ active sleep, QS ¼ quiet sleep, Prob. ¼ probability, P-C age ¼ postconceptional age, P-C age 2 ¼ quadratic effect of postconceptional age, methylxan. ¼ methylxanthine (theophylline or caffeine) treatment, mech. vent. ¼ mechanical ventilation, age X M.V. ¼ interaction of postconceptional age with mechanical ventilation, Age X Meth. ¼ interaction of postconceptional age with methylxantine treatment. w For the mixed models, the intercept parameter equals the log of expected value for the group at 29 weeks minus the effects of any covariates; the postconceptional age parameter equals the slope of the log of the variable. For the GEE models, the intercept parameter equals the log odds for the group at 29 weeks minus the effects of any covariates; the postconceptional age parameter equals the slope of the log odds for the variable. The mixed model is tested with an F-test, and the GEE model with a w 2 -test. *p<0.05; **p<0.01; ***p<0.001. and higher respiration rates in active and quiet sleep. In addition, there was an interaction between postconceptional age and mechanical ventilation for variability in respiration rate in active sleep, such that infants younger than 38 weeks showed a decrease in variability with longer mechanical ventilation whereas older infants showed an increase. Infants from the southeastern hospital had fewer respiratory pauses per hour of both sleep states and lower probability of periodic respiration in both sleep states. Gender did not affect any variable.
Comparison of Respiratory Variables in Active and Quiet Sleep
In the analyses comparing the respiratory variables between active and quiet sleep, the mean length of respiratory pauses was 0. 
Sources of Hospital-Related Differences
As the hospital-related differences in respiratory pauses per hour of both sleep states and periodic respiration in both sleep states were probably due to variables that differed between the hospitals but were not included in the models, we explored the effects of treatments and illness severity. Nine treatment and severity variables F neurological insults measured on the NBRS, indomethicin treatment, number of infections, fentanyl treatment, days of methylxanthines, cisapride treatment, metoclopramide treatment, ranitidine treatment, and multiple birth F that differed between the hospitals with p<0.10 were regressed. The illness and treatment variables were added to the statistical models for the respiratory pause frequency and periodic respiration without the hospital factor. Nonsignificant illness variables were eliminated and then the hospital factor was returned to the model. None of these variables was significant for the number of respiratory pauses per hour of active sleep. The addition of cisapride treatment reduced the hospital effects for the number of respiratory pauses per hour of quiet sleep and for periodic respiration in active sleep, but the hospital differences remained significant. The addition of cisapride treatment resulted in nonsignificant hospital effects for periodic respiration in quiet sleep.
SIGNIFICANCE
Significant development of respiration occurs over the preterm and early post-term periods. All respiratory variables, except the length of respiratory pauses in quiet sleep, decreased over the preterm period. The rate of this decrease slowed after term for four variables, as shown by significant quadratic effects. In addition, all respiratory variables, except variability of respiratory pause lengths and periodic respiration, differed by sleep state.
Previous research has also shown decreases over the preterm period in pathologic apnea and respiratory pause length and frequency. 4, 12, 13, 26, 27 However, this study is one of only four 4, 5, 11 to examine whether these developmental changes continue through the early post-term period, and the only one to use appropriate longitudinal statistics to model development. Thus, this is the first study to show that while most respiratory variables show linear decreases over the preterm and early post-term periods, the rate of decrease slows after term for several variables. Our study is also the first to show that respiratory development within individuals is similar to group patterns.
Our study also indicated that these developmental patterns were affected by other variables including sleep state. The mean length of respiratory pauses was longer in quiet sleep, but the frequency was higher in active sleep. Respiration rates were higher and more variable in active sleep. Similar findings have been reported in other studies. [7] [8] [9] [10] [11] [12] [13] [14] [15] The higher rate of respiratory pauses in active sleep may be due to the increased breath-to-breath variability and slightly decreased oxygenation known to occur in this state. 36 Although periodic respiration includes respiratory pauses, sleep state did not affect the amount of periodic respiration, similar to the findings of most other studies 11, 12, 18 however, a few studies found that periodic respiration occurred more often in active sleep. 8, 16, 17 This is the first study to show that the state-related differences continue into the post-term period largely unchanged, with the exception that the difference in respiration rates between active and quiet sleep was larger in the early post-term period than in the preterm period.
Methylxanthine treatment affected eight of the 14 respiratory variables, resulting in shorter, less variable, and less frequent respiratory pauses, less likelihood of periodic respiration, and higher respiration rates, as would be expected based on its pharmacological actions. 37, 38 Other studies have had similar findings, 12 but this study showed these findings also apply to the early post-term period. Pathologic apnea, however, was not affected by methylxanthine treatment even though methylxanthines are given to treat pathologic apnea. This finding is probably artifactual since our study was begun when the infants were no longer critical. As a result, very few subjects were studied prior to receiving methylxanthines; most were studied during methylxanthine treatment and after discontinuing treatment. Thus, our findings indicate that infants were not showing rebounds in the amount of pathologic apnea after discontinuation of caffeine or theophylline.
Other covariates had minor effects. Larger birthweights were related to longer respiratory pauses in active sleep, and longer mechanical ventilation related to fewer respiratory pauses in active sleep, higher respiration rates in active and quiet sleep, and a change in variability with age in respiration rates in active sleep. Minority infants had fewer respiratory pauses per hour of quiet sleep than white infants. Other studies found that infants with chronic lung disease (and thus longer mechanical ventilation and lower birthweights) had fewer respiratory pauses and higher respiration rates than other preterms. 6, 12, 39 Gender had no effect on respiratory variables even though previous studies found that girls had more and longer respiratory pauses and more periodic respiration. 14, 19 Finally, the hospital that cared for the infant affected four variables: the frequency of respiratory pauses and periodic respiration in both sleep states. These hospital differences could be partially explained for three variables by hospital-related differences in cisapride treatment. Cisapride affects gastroesophogeal reflux and cardiac repolarization and has been found in a couple of studies to decrease reflux-induced apnea, 40, 41 although another study did not find this effect. 42 It is unlikely that cisapride's effects on gastroesophogeal reflux could be the sole source of these effects since the respiratory variables were not related to ranitidine, which differed among the hospitals, or metoclopramide, which did not. Given the exploratory nature of these analyses, additional study is needed about the relationship between cisapride and respiration in preterms.
Overall, the effect of the covariates was small, affecting variable amounts somewhat, but not the developmental slope, except for the variability of respiration rate in active sleep. This suggests that respiratory development has a strong biological basis and, thus, might be used to indicate underlying brain functioning. Functional brain development can be represented by tracking the maturation of sleep-wake states; as a result, prediction of developmental outcomes from sleep-wake development has been suggested. 43, 44 Similarly, the development of respiration during the preterm and early post-term periods might be used a surrogate for CNS organization and maturation. Infants with respiratory patterns that differ markedly from other preterms may be more likely to exhibit abnormal neurological development. Finally, developmental patterns of respiration might also differentiate between infants with similar neurological insults in order to determine those with the greatest potential for positive outcomes as the result of neural plasticity.
